Articles

Raloxifene: a new choice for treating and preventing osteoporosis.

Author

Licata AA, Ciaccia AV, Wong M

Date

4/2000

Journal

Cleve Clin J Med

Abstract

Selective estrogen receptor modulators (SERMs) are a new class of drugs that provide a new option for addressing the health challenges of postmenopausal women. This review discusses the proposed mechanism of action of SERMs and describes clinical findings on raloxifene, a SERM now available for treating and preventing osteoporosis.